BACKGROUND: There is conflicting evidence regarding the effects of breast-feeding on maternal mortality from human immunodeficiency virus type 1 (HIV-1) infection, and little is known about the effects of breast-feeding on markers of HIV-1 disease progression. METHODS: HIV-1-seropositive women were enrolled during pregnancy and received short-course zidovudine. HIV-1 RNA levels and CD4 cell counts were determined at baseline and at months 1, 3, 6, 12, 18, and 24 postpartum and were compared between breast-feeding and formula-feeding mothers. RESULTS: Of 296 women, 98 formula fed and 198 breast-fed. At baseline, formula-feeding women had a higher education level and prevalence of HIV-1-related illness than did breast-feeding women; however, the groups did not differ with respect to CD4 cell counts and HIV-1 RNA levels. Between months 1 and 24 postpartum, CD4 cell counts decreased 3.9 cells/ microL/month (P<.001), HIV-1 RNA levels increased 0.005 log(10) copies/mL/month (P=.03), and body mass index (BMI) decreased 0.03 kg/m(2)/month (P<.001). The rate of CD4 cell count decline was higher in breast-feeding mothers (7.2 cells/ microL/month) than in mothers who never breast-fed (4.0 cells/ microL/month) (P=.01). BMI decreased more rapidly in breast-feeding women (P=.04), whereas HIV-1 RNA levels and mortality did not differ significantly between breast-feeding and formula-feeding women. CONCLUSIONS: Breast-feeding was associated with significant decreases in CD4 cell counts and BMI. HIV-1 RNA levels and mortality were not increased, suggesting a limited adverse impact of breast-feeding in mothers receiving extended care for HIV-1 infection.
BACKGROUND: There is conflicting evidence regarding the effects of breast-feeding on maternal mortality from human immunodeficiency virus type 1 (HIV-1) infection, and little is known about the effects of breast-feeding on markers of HIV-1 disease progression. METHODS:HIV-1-seropositive women were enrolled during pregnancy and received short-course zidovudine. HIV-1 RNA levels and CD4 cell counts were determined at baseline and at months 1, 3, 6, 12, 18, and 24 postpartum and were compared between breast-feeding and formula-feeding mothers. RESULTS: Of 296 women, 98 formula fed and 198 breast-fed. At baseline, formula-feeding women had a higher education level and prevalence of HIV-1-related illness than did breast-feeding women; however, the groups did not differ with respect to CD4 cell counts and HIV-1 RNA levels. Between months 1 and 24 postpartum, CD4 cell counts decreased 3.9 cells/ microL/month (P<.001), HIV-1 RNA levels increased 0.005 log(10) copies/mL/month (P=.03), and body mass index (BMI) decreased 0.03 kg/m(2)/month (P<.001). The rate of CD4 cell count decline was higher in breast-feeding mothers (7.2 cells/ microL/month) than in mothers who never breast-fed (4.0 cells/ microL/month) (P=.01). BMI decreased more rapidly in breast-feeding women (P=.04), whereas HIV-1 RNA levels and mortality did not differ significantly between breast-feeding and formula-feeding women. CONCLUSIONS: Breast-feeding was associated with significant decreases in CD4 cell counts and BMI. HIV-1 RNA levels and mortality were not increased, suggesting a limited adverse impact of breast-feeding in mothers receiving extended care for HIV-1 infection.
Authors: N Shaffer; R Chuachoowong; P A Mock; C Bhadrakom; W Siriwasin; N L Young; T Chotpitayasunondh; S Chearskul; A Roongpisuthipong; P Chinayon; J Karon; T D Mastro; R J Simonds Journal: Lancet Date: 1999-03-06 Impact factor: 79.321
Authors: S Emery; S Bodrug; B A Richardson; C Giachetti; M A Bott; D Panteleeff; L L Jagodzinski; N L Michael; R Nduati; J Bwayo; J K Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 2000-07 Impact factor: 5.948
Authors: R Nduati; B A Richardson; G John; D Mbori-Ngacha; A Mwatha; J Ndinya-Achola; J Bwayo; F E Onyango; J Kreiss Journal: Lancet Date: 2001-05-26 Impact factor: 79.321
Authors: K Anastos; S J Gange; B Lau; B Weiser; R Detels; J V Giorgi; J B Margolick; M Cohen; J Phair; S Melnick; C R Rinaldo; A Kovacs; A Levine; S Landesman; M Young; A Muñoz; R M Greenblatt Journal: J Acquir Immune Defic Syndr Date: 2000-07-01 Impact factor: 3.731
Authors: B Lohman-Payne; T Sandifer; M OhAinle; C Crudder; J Lynch; M M Omenda; J Maroa; K Fowke; G C John-Stewart; C Farquhar Journal: Clin Exp Immunol Date: 2014-10 Impact factor: 4.330
Authors: S R Jonnalagadda; E Brown; B Lohman-Payne; D Wamalwa; C Farquhar; G C John-Stewart Journal: Int J Tuberc Lung Dis Date: 2013-12 Impact factor: 2.373
Authors: Melanie A Gasper; Pratima Kunwar; Grace Itaya; Nicholas Lejarcegui; Rose Bosire; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Jennifer Slyker; Julie Overbaugh; Helen Horton; Donald L Sodora; Grace John-Stewart; Barbara Lohman-Payne Journal: AIDS Date: 2014-05-15 Impact factor: 4.177
Authors: Pamela M Murnane; Stephen M Arpadi; Moses Sinkala; Chipepo Kankasa; Mwiya Mwiya; Prisca Kasonde; Donald M Thea; Grace M Aldrovandi; Louise Kuhn Journal: Int J Epidemiol Date: 2010-05-19 Impact factor: 7.196
Authors: Lara C Diener; Jennifer A Slyker; Christine Gichuhi; Kenneth A Tapia; Barbra A Richardson; Dalton Wamalwa; Carey Farquhar; Julie Overbaugh; Elizabeth Maleche-Obimbo; Grace John-Stewart Journal: AIDS Date: 2012-09-24 Impact factor: 4.177
Authors: Jennifer A Slyker; Barbara L Lohman-Payne; Sarah L Rowland-Jones; Phelgona Otieno; Elizabeth Maleche-Obimbo; Barbra Richardson; Carey Farquhar; Dorothy Mbori-Ngacha; Vincent C Emery; Grace C John-Stewart Journal: AIDS Date: 2009-01-02 Impact factor: 4.177
Authors: Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart Journal: AIDS Date: 2008-08-20 Impact factor: 4.177